“The DEA has taken an important step to enhance data transparency and address a persistent information gap between the agency and its supply chain registrants. HDA and the nation’s primary pharmaceutical distributors have long advocated for increased information sharing through greater access to data from the Automation of Reports and Consolidated Orders System (ARCOS). Facilitated through the newly enacted SUPPORT for Patients and Communities Act, this resource will enable distributors and their supply chain partners to view a more complete picture of controlled substance sales.
“HDA and its distributor members look forward to continued collaboration with DEA and other stakeholders as the SUPPORT Act is implemented, and we continue to seek forward-looking solutions to end the nation’s prescription opioid abuse epidemic.”
For more information on pharmaceutical distribution industry efforts to combat the prescription opioid epidemic, visit the HDA website.